Beam Therapeutics Inc (BEAM)
21.88
-0.67
(-2.97%)
USD |
NASDAQ |
May 08, 14:05
Beam Therapeutics Price: 21.88 for May 8, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 07, 2024 | 22.76 | 22.93 | 21.67 | 22.55 | 1.152M |
May 06, 2024 | 23.34 | 23.71 | 22.66 | 22.78 | 926235.0 |
May 03, 2024 | 23.64 | 24.60 | 22.94 | 23.13 | 1.226M |
May 02, 2024 | 22.08 | 23.06 | 22.00 | 22.72 | 1.103M |
May 01, 2024 | 21.27 | 22.83 | 21.01 | 21.74 | 1.498M |
Apr 30, 2024 | 21.56 | 21.90 | 21.08 | 21.22 | 1.448M |
Apr 29, 2024 | 21.75 | 22.68 | 21.52 | 22.05 | 912368.0 |
Apr 26, 2024 | 21.74 | 21.95 | 21.11 | 21.38 | 1.243M |
Apr 25, 2024 | 22.00 | 22.55 | 20.84 | 21.60 | 1.743M |
Apr 24, 2024 | 23.56 | 23.85 | 22.63 | 22.74 | 1.110M |
Apr 23, 2024 | 24.04 | 25.47 | 23.44 | 23.47 | 1.400M |
Apr 22, 2024 | 24.27 | 24.27 | 23.20 | 24.10 | 2.435M |
Apr 19, 2024 | 24.14 | 24.94 | 23.64 | 23.90 | 4.537M |
Apr 18, 2024 | 24.19 | 24.78 | 24.05 | 24.31 | 1.714M |
Apr 17, 2024 | 26.06 | 26.14 | 24.14 | 24.31 | 1.443M |
Apr 16, 2024 | 25.23 | 25.90 | 24.84 | 25.70 | 1.676M |
Apr 15, 2024 | 26.20 | 26.42 | 25.14 | 25.70 | 2.234M |
Apr 12, 2024 | 26.99 | 26.99 | 25.52 | 25.93 | 1.299M |
Apr 11, 2024 | 27.49 | 27.52 | 26.67 | 27.27 | 1.069M |
Apr 10, 2024 | 27.52 | 27.69 | 26.69 | 27.06 | 3.284M |
Apr 09, 2024 | 28.86 | 29.34 | 28.20 | 29.32 | 776406.0 |
Apr 08, 2024 | 28.36 | 28.86 | 28.01 | 28.81 | 850406.0 |
Apr 05, 2024 | 28.51 | 28.74 | 28.03 | 28.20 | 1.506M |
Apr 04, 2024 | 29.75 | 30.12 | 28.90 | 29.03 | 944402.0 |
Apr 03, 2024 | 30.18 | 30.72 | 29.59 | 29.68 | 1.166M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.31
Minimum
Mar 16 2020
133.60
Maximum
Jul 01 2021
49.46
Average
38.81
Median
Mar 02 2023
Price Benchmarks
Eli Lilly and Co | 777.25 |
Moderna Inc | 122.25 |
Editas Medicine Inc | 5.005 |
Intellia Therapeutics Inc | 22.93 |
Perspective Therapeutics Inc | 1.75 |
Price Related Metrics
PS Ratio | 4.468 |
Price to Book Value | 1.821 |
Earnings Yield | -8.68% |
Market Cap | 1.787B |